Comparison of clinical outcomes of overlapping sirolimus- versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention

被引:12
作者
Chu, William W. [1 ]
Kuchulakanti, Pramod K. [1 ]
Torguson, Rebecca [1 ]
Wang, Betty [1 ]
Clavijo, Leonardo C. [1 ]
Suddath, William O. [1 ]
Pichard, Augusto D. [1 ]
Satler, Lowell F. [1 ]
Kent, Kenneth M. [1 ]
Waksman, Ron [1 ]
机构
[1] Washington Hosp Ctr, Div Cardiol, Washington, DC 20010 USA
关键词
D O I
10.1016/j.amjcard.2006.07.032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sirolimus-eluting stent (SES) and paclitaxel-eluting stent (PES) implantation for the treatment of single coronary lesions has proved to be effective and durable. However, the safety and efficacy of overlapping drug-eluting stents for the treatment of long lesions have not been well established. In total, 114 patients who received overlapping drug-eluting stents were identified, 55 of whom received overlapping SESs and 59 received overlapping PESs. Baseline clinical and angiographic characteristics were balanced. In-hospital complications were similar between the 2 groups. At 30-day and 6-month follow-ups, all clinical outcomes were also similar. In addition, the event-free survival rate was comparable (p = 0.71). Implantation of overlapping drug-eluting stents for the treatment of long, native coronary lesions is feasible and effective. In conclusion, in this observational study, clinical outcomes appeared similar in patients treated with overlapping SES implantation compared with those treated with overlapping PES implantation. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1563 / 1566
页数:4
相关论文
共 13 条
[1]   Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention [J].
Chu, WW ;
Kuchulakanti, PK ;
Torguson, R ;
Wang, B ;
Clavijo, LC ;
Suddath, WO ;
Pichard, AD ;
Satler, LF ;
Kent, KM ;
Waksman, R .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2006, 67 (04) :595-599
[2]   Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions [J].
Colombo, A ;
Drzewiecki, J ;
Banning, A ;
Grube, E ;
Hauptmann, K ;
Silber, S ;
Dudek, D ;
Fort, S ;
Schiele, F ;
Zmudka, K ;
Guagliumi, G ;
Russell, ME .
CIRCULATION, 2003, 108 (07) :788-794
[3]   Very long sirolimus-eluting stent implantation for de novo coronary lesions [J].
Degertekin, M ;
Arampatzis, CA ;
Lemos, PA ;
Saia, F ;
Hoye, A ;
Daemen, J ;
Tanabe, K ;
Lee, CH ;
Hofma, SJ ;
Sianos, G ;
McFadden, E ;
van der Giessen, W ;
Smits, PC ;
De Feyter, PJ ;
van Domburg, RT ;
Serruys, PW .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (07) :826-829
[4]   Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions [J].
Grube, E ;
Silber, S ;
Hauptmann, KE ;
Mueller, R ;
Buellesfeld, L ;
Gerckens, U ;
Russell, ME .
CIRCULATION, 2003, 107 (01) :38-42
[5]   Influence of lesion length on restenosis after coronary stent placement [J].
Kastrati, A ;
Elezi, S ;
Dirschinger, J ;
Hadamitzky, M ;
Neumann, FJ ;
Schömig, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (12) :1617-1622
[6]   Overlapping vs. one long stenting in long coronary lesions [J].
Lee, SH ;
Jang, Y ;
Oh, SJ ;
Park, KJ ;
Moon, YS ;
Min, JW ;
Yang, JY ;
Jang, GJ .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2004, 62 (03) :298-302
[7]   A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. [J].
Morice, M ;
Serruys, PW ;
Sousa, JE ;
Fajadet, J ;
Hayashi, EB ;
Perin, M ;
Colombo, A ;
Schuler, G ;
Barragan, P ;
Guagliumi, G ;
Molnar, F ;
Falotico, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23) :1773-1780
[8]   Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions - The REALITY trial: A randomized controlled trial [J].
Morice, MC ;
Colombo, A ;
Meier, B ;
Serruys, P ;
Tamburino, C ;
Guagliumi, G ;
Sousa, E ;
Stoll, HP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (08) :895-904
[9]   Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery [J].
Moses, JW ;
Leon, MB ;
Popma, JJ ;
Fitzgerald, PJ ;
Holmes, DR ;
O'Shaughnessy, C ;
Caputo, RP ;
Kereiakes, DJ ;
Williams, DO ;
Teirstein, PS ;
Jaeger, JL ;
Kuntz, RE .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (14) :1315-1323